Michał Stefan Lach Selected Research

Uveal melanoma

1/2022	MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression.
7/2021	The Analysis of Inflammation-Related Proteins in a Cargo of Exosomes Derived from the Serum of Uveal Melanoma Patients Reveals Potential Biomarkers of Disease Progression.
1/2020	The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michał Stefan Lach Research Topics

Disease

3	Uveal melanoma 01/2022 - 01/2020
3	Neoplasms (Cancer) 07/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2021
2	Disease Progression 07/2021 - 01/2020
1	Inflammation (Inflammations) 07/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Monosomy 01/2020
1	Joint Diseases (Joint Disease) 06/2019

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
1	Interleukin-2 (IL2)IBA 07/2021
1	Proteins (Proteins, Gene)FDA Link 07/2021
1	Interferon-gamma (Interferon, gamma)IBA 07/2021
1	IonophoresIBA 01/2020
1	salinomycinIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	PlatinumIBA 01/2020
1	human MIRN1247 microRNAIBA 01/2020
1	human MIRN592 microRNAIBA 01/2020
1	human MIRN346 microRNAIBA 01/2020
1	human MIRN506 microRNAIBA 01/2020

Therapy/Procedure

1	Therapeutics 06/2019